Juzeniene A, Stenberg VY, Bruland ØS, Revheim ME, Larsen RH(2023) Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach Front Med (Lausanne), 9, 1051825 DOI 10.3389/fmed.2022.1051825, PubMed 36733936
Ghiasvand R, Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Karlstad Ø, Juzeniene A, Larsen IK, Green AC, Veierød MB, Robsahm TE(2022) Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study Int J Epidemiol(in press) DOI 10.1093/ije/dyac223, PubMed 36413027
Stenberg VY, Tornes AJK, Nilsen HR, Revheim ME, Bruland ØS, Larsen RH, Juzeniene A(2022) Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001 Cancers (Basel), 14(11) DOI 10.3390/cancers14112784, PubMed 35681766